Last updated: 2026-10-11 14:27:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Nuwellis, Inc. (NUWE) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0,68, with a market capitalization of $2,19M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,67 to $172,90. This page covers its latest market performance, valuation, price trends and company information.
$2,19M | |
$0,70 | |
$27 731 550,00 | |
$0,67 | |
$0,68 | |
136,93K | |
4,40M | |
-- | |
$172,90 | |
$0,67 | |
-- | |
-- |
Nuwellis, Inc. (NUWE) last closed at $0,68 as of 2026-10-09 23:31:00, unchanged from the previous close of $0,68.
During the latest regular trading session, NUWE traded between $0,67 and $27 731 550,00, with a volume of 136,93K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Nuwellis, Inc. (NUWE) moved from $0,75 to $0,68, representing a decline of 8,68% ($0,06).
The stock traded between $0,67 and $0,78 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 144,51 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0,0%
NUWE is currently trading at $0,68, placing it 0,0% of the way from its 52-week low of $0,67 to its 52-week high of $172,90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 38 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Nuwellis, Inc. (NUWE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.